BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 12771265)

  • 1. Idebenone treatment in Friedreich's ataxia: neurological, cardiac, and biochemical monitoring.
    Buyse G; Mertens L; Di Salvo G; Matthijs I; Weidemann F; Eyskens B; Goossens W; Goemans N; Sutherland GR; Van Hove JL
    Neurology; 2003 May; 60(10):1679-81. PubMed ID: 12771265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial.
    Mariotti C; Solari A; Torta D; Marano L; Fiorentini C; Di Donato S
    Neurology; 2003 May; 60(10):1676-9. PubMed ID: 12771264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idebenone for treatment of Friedreich's ataxia?
    Filla A; Moss AJ
    Neurology; 2003 May; 60(10):1569-70. PubMed ID: 12771240
    [No Abstract]   [Full Text] [Related]  

  • 4. Heart hypertrophy and function are improved by idebenone in Friedreich's ataxia.
    Rustin P; Rötig A; Munnich A; Sidi D
    Free Radic Res; 2002 Apr; 36(4):467-9. PubMed ID: 12069112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia.
    Hausse AO; Aggoun Y; Bonnet D; Sidi D; Munnich A; Rötig A; Rustin P
    Heart; 2002 Apr; 87(4):346-9. PubMed ID: 11907009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Successful idebenone therapy of hypertrophic cardiomyopathy in Friedreich ataxia].
    Kádár K
    Orv Hetil; 2003 Jun; 144(25):1241-4. PubMed ID: 12901180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA).
    Lagedrost SJ; Sutton MS; Cohen MS; Satou GM; Kaufman BD; Perlman SL; Rummey C; Meier T; Lynch DR
    Am Heart J; 2011 Mar; 161(3):639-645.e1. PubMed ID: 21392622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study.
    Rustin P; von Kleist-Retzow JC; Chantrel-Groussard K; Sidi D; Munnich A; Rötig A
    Lancet; 1999 Aug; 354(9177):477-9. PubMed ID: 10465173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial.
    Di Prospero NA; Baker A; Jeffries N; Fischbeck KH
    Lancet Neurol; 2007 Oct; 6(10):878-86. PubMed ID: 17826341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial.
    Rustin P; Bonnet D; Rötig A; Munnich A; Sidi D
    Neurology; 2004 Feb; 62(3):524-5; author reply 525; discussion 525. PubMed ID: 14872056
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurological, cardiological, and oculomotor progression in 104 patients with Friedreich ataxia during long-term follow-up.
    Ribaï P; Pousset F; Tanguy ML; Rivaud-Pechoux S; Le Ber I; Gasparini F; Charles P; Béraud AS; Schmitt M; Koenig M; Mallet A; Brice A; Dürr A
    Arch Neurol; 2007 Apr; 64(4):558-64. PubMed ID: 17420319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Friedreich's ataxia: idebenone treatment in early stage patients.
    Artuch R; Aracil A; Mas A; Colomé C; Rissech M; Monrós E; Pineda M
    Neuropediatrics; 2002 Aug; 33(4):190-3. PubMed ID: 12368988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich ataxia.
    Seznec H; Simon D; Monassier L; Criqui-Filipe P; Gansmuller A; Rustin P; Koenig M; Puccio H
    Hum Mol Genet; 2004 May; 13(10):1017-24. PubMed ID: 15028670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Friedreich's Ataxia: disease mechanisms, antioxidant and Coenzyme Q10 therapy.
    Cooper JM; Schapira AH
    Biofactors; 2003; 18(1-4):163-71. PubMed ID: 14695932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idebenone in Friedreich's ataxia.
    Tonon C; Lodi R
    Expert Opin Pharmacother; 2008 Sep; 9(13):2327-37. PubMed ID: 18710357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose idebenone treatment in Friedreich's ataxia with and without cardiac hypertrophy.
    Rinaldi C; Tucci T; Maione S; Giunta A; De Michele G; Filla A
    J Neurol; 2009 Sep; 256(9):1434-7. PubMed ID: 19363628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring cardiac function during idebenone therapy in Friedreich's ataxia.
    Giovanni DS; Valeria P; Bahaa F; Majid AF
    Curr Pharm Des; 2015; 21(4):479-83. PubMed ID: 25483949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heart involvement in Friedreich's ataxia].
    Weidemann F; Scholz F; Florescu C; Liu D; Hu K; Herrmann S; Ertl G; Störk S
    Herz; 2015 Mar; 40 Suppl 1():85-90. PubMed ID: 24848865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked variation in the cardiomyopathy associated with Friedreich's ataxia.
    Dutka DP; Donnelly JE; Nihoyannopoulos P; Oakley CM; Nunez DJ
    Heart; 1999 Feb; 81(2):141-7. PubMed ID: 9922348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Friedreich's ataxia associated with idiopathic hypertrophic subaortic stenosis.
    Ruschhaupt DG; Thilenius OG; Cassels DE
    Am Heart J; 1972 Jul; 84(1):95-102. PubMed ID: 4673109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.